Trial Profile
Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery: a 9-month Randomized, Open-label, Controlled Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2020
Price :
$35
*
At a glance
- Drugs Mometasone (Primary) ; Montelukast (Primary)
- Indications Asthma; Rhinosinusitis
- Focus Therapeutic Use
- 19 Nov 2020 Status changed from not yet recruiting to completed.
- 05 Jul 2014 New trial record